Deletion, dose escalating scheme and response of the patients who participated in the systemic eteplirsen clinical trial.

Response to eteplirsen: + shows response only at RNA level ; ++ shows response at RNA level and increase of dystrophin expression in post-treatment muscle; +++ shows response at RNA level and a greater increase in dystrophin production in post-treatment muscle measured with three methods of quantification.